UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Russian Strikes Leave 600,000 People Without Power
Robert Pether Returning To Ireland After Five-Year Iraqi Detention
G7 Meeting To Discuss EU Diesel Shortages
Nine Gaming Companies Under Investigation By CCPC
Taoiseach Highly Critical Of Israel In UN Address
Concerns After AI Agent Hacks Australian Gov. Website